Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older

References

• The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. DOI:10.1177/0333102413485658
   PubMed Web of Science ®Google Scholar
• Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global burden of disease study 2010. Lancet. 2012;380:2071–2094.
   PubMed Web of Science ®Google Scholar
• GBD 2015 disease and injury incidence and prevalence collaborators global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545–1602. DOI:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache. 2001;41(7):646–657.
   PubMed Web of Science ®Google Scholar
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–464.
   PubMed Web of Science ®Google Scholar
• Torres-Ferr´us M, Ursitti F, Alpuente A, et al. From transformation to chronification of migraine: pathophysiological and clinical aspects.J. J Headache Pain. 2020;21(1):42. DOI:10.1186/s10194-020-01111-8
   PubMed Web of Science ®Google Scholar
• Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American migraine prevalence and prevention study. Headache. 2012;52(10):1456–1470. DOI:10.1111/j.1526-4610.2012.02223.x
   PubMed Web of Science ®Google Scholar
• Pescador Ruschel MA, De Jesus O Migraine headache. [Updated 2022 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. . Available from: https://www.ncbi.nlm.nih.gov/books/NBK560787/.
   Google Scholar
• Agostoni EC, Barbanti P, Calabresi P, et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019;20(1):92. DOI:10.1186/s10194-019-1038-4
   PubMed Web of Science ®Google Scholar
• Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Epub 2021 Jun 18. PMID: 34145431; PMCID: PMC8321897 Nat Rev Neurol. 2021;17(8):501–514. doi: 10.1038/s41582-021-00509-5
   PubMed Web of Science ®Google Scholar
• Galhardoni R, Correia GS, Araujo H, et al. Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S156–72. doi:10.1016/j.apmr.2014.11.010. Epub 2014 Nov 28. PMID: 25437106.
   PubMed Web of Science ®Google Scholar
• Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–979.
   PubMed Web of Science ®Google Scholar
• Nierenburg H, Stark-Inbar A. Nerivio® remote electrical neuromodulation for acute treatment of chronic migraine. Pain Manag. 2022 Apr;12(3):267–281. doi:10.2217/pmt-2021-0038. Epub 2021 Sep 20. PMID: 34538078.
   PubMed Web of Science ®Google Scholar
• Tashani O, Johnson M. Transcutaneous Electrical Nerve Stimulation (TENS) a Possible aid for pain relief in developing countries? Libyan J Med. 2009 Jun 1;4(2):62–65. PMID: 21483510; PMCID: PMC3066716. DOI:10.3402/ljm.v4i2.4812.
   PubMed Web of Science ®Google Scholar
• Machado AFP, Perracini MR, Rampazo ÉP, et al. Effects of thermotherapy and transcutaneous electrical nerve stimulation on patients with primary dysmenorrhea: a randomized, placebo-controlled, double-blind clinical trial. Complement Ther Med. 2019 Dec;47:102188. Epub 2019 Aug 28. PMID: 31779988. DOI:10.1016/j.ctim.2019.08.022.
   PubMed Web of Science ®Google Scholar
• de Resende MA, Silva LF, Sato K, et al. Blockade of opioid receptors in the medullary reticularis nucleus dorsalis, but not the rostral ventromedial medulla, prevents analgesia produced by diffuse noxious inhibitory control in rats with muscle inflammation. J Pain. 2011;12:687–697.
   PubMed Web of Science ®Google Scholar
• Wen YR, Wang CC, Yeh GC, et al. DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors. J Biomed Sci. 2010;17:19.
   PubMed Web of Science ®Google Scholar
• Liebano RE, Vance CG, Rakel BA, et al. Transcutaneous electrical nerve stimulation and conditioned pain modulation influence the perception of pain in humans. Eur J Pain. 2013;17(10):1539–1546.
   PubMed Web of Science ®Google Scholar
• Reddy CG, Miller JW, Abode-Iyamah KO, et al. Ovine model of neuropathic pain for assessing mechanisms of spinal cord stimulation therapy via dorsal horn recordings, von Frey filaments, and gait analysis. J Pain Res. 2018;11:1147–1162.
   PubMed Web of Science ®Google Scholar
• Shu B, He S-Q , Guan Y. Spinal cord stimulation enhances microglial activation in the spinal cord of nerve-injuredrats. Neurosci Bull. 2020;36:1441–1453.
   PubMed Web of Science ®Google Scholar
• Yuan B, Liu D, Liu X. Spinal cord stimulation exerts analgesia effects in chronic constriction injury rats via suppression of the TLR4/NF-κB pathway. Neurosci Lett. 2014;581:63–68.
   PubMed Web of Science ®Google Scholar
• Xu L, Liu Y, Sun Y, et al. Analgesic effects of TLR4/NF-κB signaling pathway inhibition on chronic neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Biomed Pharmacother. 2018;107:526–533.
   PubMed Web of Science ®Google Scholar
• Moisset X, Pereira B, Ciampi de Andrade D, et al. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2020 Dec 10;21(1):142. PMID: 33302882; PMCID: PMC7726868. DOI:10.1186/s10194-020-01204-4.
   PubMed Web of Science ®Google Scholar
• Lambru G, Lanteri-Minet M. Neuromodulation in headache and facial pain management: principles, rationale and clinical data. Switzerland AG: Springer; 2020.
   Google Scholar
• Yarnitsky D, Dodick DW, Grosberg BM, et al. Remote Electrical Neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019 Sep;59(8):1240–1252. doi:10.1111/head.13551. Epub 2019 May 9. PMID: 31074005; PMCID: PMC6767146. .
   PubMed Web of Science ®Google Scholar
• Chou DE, Shnayderman Yugrakh M, Winegarner D, et al. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019 Jan;39(1):3–14. Epub 2018 Nov 17. PMID: 30449151; PMCID: PMC6348457. DOI:10.1177/0333102418811573.
   PubMed Web of Science ®Google Scholar
• Hokenek NM, Erdogan MO, Hokenek UD, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: a randomize controlled trial. Am J Emerg Med. 2021 Jan;39:80–85. Epub 2020 Jan 15. PMID: 31983598. DOI:10.1016/j.ajem.2020.01.024.
   PubMed Web of Science ®Google Scholar
• Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018 Jul 24;91(4):e364–373. Epub 2018 Jun 15. PMID: 29907608; PMCID: PMC6070381. DOI:10.1212/WNL.0000000000005857.
   PubMed Web of Science ®Google Scholar
• Juan Y, Shu O, Jinhe L, et al. Migraine prevention with percutaneous mastoid electrical stimulator: a randomized double-blind controlled trial. Cephalalgia. 2017 Nov;37(13):1248–1256. Epub 2016 Nov 12. PMID: 27821639. DOI:10.1177/0333102416678623.
   PubMed Web of Science ®Google Scholar
• San-Juan D, Pon AA, Pohls FZ, et al. Peripheral pulsed electromagnetic fields may reduce the placebo effect in migraine patients that do not respond to the sham intervention in a randomized, placebo-controlled, double-blind, cross-over clinical trial. Complement Ther Med. 2012 Feb;20(1–2):31–37. doi:10.1016/j.ctim.2011.09.006. Epub 2011 Oct 15. PMID: 22305246.
   PubMed Web of Science ®Google Scholar
• Chaudhry SR, Lendvai IS, Muhammad S, et al. Inter-ictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation (nVNS): a proof-of-concept study. Brain Stimul. 2019 May;12(3):643–651. doi:10.1016/j.brs.2019.01.008. Epub 2019 Jan 19. PMID: 30745260.
   PubMed Web of Science ®Google Scholar
• Renner T, Sollmann N, Heinen F, et al. Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles - a randomized trial. Sci Rep. 2020 Apr 6;10(1):5954. PMID: 32249788; PMCID: PMC7136237. DOI:10.1038/s41598-020-62701-9.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010 Apr;9(4):373–380. doi:10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4. PMID: 20206581.
   PubMed Web of Science ®Google Scholar
• Kalita J, Laskar S, Bhoi SK, et al. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016 Nov;263(11):2238–2246. doi:10.1007/s00415-016-8257-2. Epub 2016 Aug 19. PMID: 27541044.
   PubMed Web of Science ®Google Scholar
• Amin R, Emara T, Ashour S, et al. The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis. Egypt J Neurol Psychiatry Neurosurg. 2020;56(19). DOI:10.1186/s41983-019-0140-5.
   Google Scholar
• Teepker M, Hötzel J, Timmesfeld N, et al. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia. 2010 Feb;30(2):137–144. PMID: 19515124. DOI:10.1111/j.1468-2982.2009.01911.x.
   PubMed Web of Science ®Google Scholar
• Antal A, Kriener N, Lang N, et al. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011 May;31(7):820–828. Epub 2011 Mar 11. PMID: 21398419. DOI:10.1177/0333102411399349.
   PubMed Web of Science ®Google Scholar
• Juto J-E, Hallin RG. Kinetic oscillation stimulation as treatment of acute migraine: a randomized, controlled pilot study. Headache. 2015;55:117–127.
   PubMed Web of Science ®Google Scholar
• Li H, Xu QR. Effect of percutaneous electrical nerve stimulation for the treatment of migraine. Medicine (Baltimore). 2017 Sep;96(39):e8108. doi:10.1097/MD.0000000000008108. PMID: 28953632; PMCID: PMC5626275.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng H, Witt CM, et al. Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ. 2012 Mar 6;184(4):401–410. Epub 2012 Jan 9. PMID: 22231691; PMCID: PMC3291669. DOI:10.1503/cmaj.110551.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012 Dec;32(16):1165–1179. Epub 2012 Oct 3. Erratum in: Cephalalgia. 2014 Oct;34(11):944. Vaisma, Julien [corrected to Vaisman, Julien]. Erratum in: Cephalalgia. 2014 Oct;34(11):944. PMID: 23034698. DOI:10.1177/0333102412462642.
   PubMed Web of Science ®Google Scholar
• Saper JR, Dodick DW, Silberstein SD, et al. ONSTIM Investigators. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: oNSTIM feasibility study. Cephalalgia. 2011 Feb;31(3):271–285. Epub 2010 Sep 22. PMID: 20861241; PMCID: PMC3057439. DOI:10.1177/0333102410381142.
   PubMed Web of Science ®Google Scholar
• Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012;15:245–253.
   PubMed Web of Science ®Google Scholar
• Rizvi S, Khan AM. Use of transcranial magnetic stimulation for depression. Cureus. 2019 May 23;11(5):e4736. PMID: 31355095; PMCID: PMC6649915. DOI:10.7759/cureus.4736.
   PubMed Web of Science ®Google Scholar
• Ailani J, Burch RC, Robbins MS. Board of directors of the American headache society. The American headache society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–1039.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. Chronic migraine. BMJ. 2014 Mar 24;348:g1416. doi:10.1136/bmj.g1416. PMID: 24662044.
   PubMedGoogle Scholar
• Nierenburg H, Vieira JR, Lev N, et al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther. 2020 Dec;9(2):531–543. doi:10.1007/s40122-020-00185-1. Epub 2020 Jul 9. PMID: 32648205; PMCID: PMC7648773.
   PubMed Web of Science ®Google Scholar
• Clark O, Mahjoub A, Osman N, et al. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Neurological Science. 2022;43:1.
   PubMed Web of Science ®Google Scholar
• Yarnitsky D, Volokh L, Ironi A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017 Mar 28;88(13):1250–1255. doi: 10.1212/WNL.0000000000003760. Epub 2017 Mar 1. PMID: 28251920.
   PubMed Web of Science ®Google Scholar
• Hershey AD, Lin T, Gruper Y, et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache. 2021 Feb;61(2):310–317. doi:10.1111/head.14042. Epub 2020 Dec 21. PMID: 33349920.
   PubMed Web of Science ®Google Scholar
• Nir RR, Granovsky Y, Yarnitsky D, et al. A psychophysical study of endogenous analgesia: the role of the conditioning pain in the induction and magnitude of conditioned pain modulation. Eur J Pain. 2011;15:491–497.
   PubMed Web of Science ®Google Scholar
• Lautenbacher S, Roscher S, Strian F. Inhibitory effects do not depend on the subjective experience of pain during heterotopic noxious conditioning stimulation (Hncs): a contribution to the psychophysics of pain inhibition. Eur J Pain. 2002;6:365–374.
   PubMed Web of Science ®Google Scholar
• Johnson MI, Paley CA, Howe TE, et al. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev. 2015 6;2021:CD006142. DOI:10.1002/14651858.CD006142.pub3
   Google Scholar
• Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;2013(4). DOI:10.1002/14651858.CD008039.pub3 CD008039 PMID: 23633348; PMCID: PMC6457976.
   Google Scholar
• Trent AR, Chopra P, Jain A. Peripheral Nerve Stimulator. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Updated 2022 Mar 22]. In: StatPearls [Internet.
   Google Scholar
• Hershey AD, Irwin S, Rabany L, et al. Comparison of remote electrical neuromodulation and standard-care medications for acute treatment of migraine in adolescents: a post Hoc analysis. Pain Med. 2022 Apr 8;23(4):815–820. doi: 10.1093/pm/pnab197. PMID: 34185084.
   PubMed Web of Science ®Google Scholar
• Rapoport AM, Bonner JH, Lin T, et al. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications**Pivotal Study. Summary: Significant efficacy and safety of REN as well as its comparability with and independent efficacy from usual treatment is shown. J Headache Pain. 2019 Jul 22;20(1):83. PMID: 31331265; PMCID: PMC6734294. DOI:10.1186/s10194-019-1033-9.
   PubMedGoogle Scholar
• Marmura MJ, Lin T, Harris D, et al. Incorporating Remote Electrical Neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11. doi: 10.3389/fneur.2020.00226.
   PubMed Web of Science ®Google Scholar
• Grosberg B, Rabany L, Lin T, et al. Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study. Pain Rep. 2021 Oct 14;6(4):e966. doi: 10.1097/PR9.0000000000000966. PMID: 34667919; PMCID: PMC8519197.
   PubMedGoogle Scholar
• Ailani J, Rabany L, Tamir S, et al. Real-World Analysis of Remote Electrical Neuromodulation (REN) for the acute treatment of migraine. Front Pain Res (Lausanne). 2022 Jan 18;2:753736. doi: 10.3389/fpain.2021.753736. PMID: 35295483; PMCID: PMC8915560.
   PubMedGoogle Scholar
• Tepper SJ, Lin T, Montal T, et al. Real-world experience with remote electrical neuromodulation in the acute treatment of migraine. Pain Med. 2020 Dec 25;21(12):3522–3529. doi: 10.1093/pm/pnaa299. PMID: 32935848.
   PubMed Web of Science ®Google Scholar
• Nierenburg H, Rabany L, Lin T, et al. Remote Electrical Neuromodulation (REN) for the acute treatment of menstrual migraine: a retrospective survey study of effectiveness and tolerability. Pain Ther. 2021 Dec;10(2):1245–1253. doi:10.1007/s40122-021-00276-7. Epub 2021 Jun 17. PMID: 34138449; PMCID: PMC8586055. .
   PubMed Web of Science ®Google Scholar
• Buse DC, Rabany L, Lin T, et al. Combining Guided Intervention of Education and Relaxation (GIER) with Remote Electrical Neuromodulation (REN) in the acute treatment of migraine. Pain Med. 2022 Aug 31;23(9):1544–1549. PMID: 35148414. DOI:10.1093/pm/pnac021.
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Rabany L, Cowan RP, et al. Remote electrical neuromodulation for migraine prevention: a double-blind, randomized, placebo-controlled clinical trial. Headache. 2023 Jan 27;63(3):377–389. doi: 10.1111/head.14469. Epub ahead of print. PMID: 36704988.
   PubMed Web of Science ®Google Scholar
• Ha H, Gonzalez A. Migraine headache prophylaxis. Am Fam Physician. 2019 Jan 1;99(1):17–24. PMID: 30600979.
   PubMed Web of Science ®Google Scholar
• Diener HC, Holle D, Solbach K, et al. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12(10):575–583.
   PubMed Web of Science ®Google Scholar
• Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National health interview survey. Headache J Head Face Pain. 1993;33(1):29–35.
   PubMed Web of Science ®Google Scholar
• Kristoffersen ES, Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014;5(2):87–99.
   PubMedGoogle Scholar